Molecular markers for the efficacy of neoadjuvant immunotherapy for head and neck squamous cell carcinoma
{{output}}
Cancer ranks among the most formidable diseases. Currently, the treatment of malignant tumors has entered the immunotherapy era. Immunotherapy has achieved remarkable progress in treating malignant tumors, including head neck squamous cell carcinoma. Neverthel... ...
